The International Journal of Biological Markers · 2011 · 34 citations · 25 references
MedicineOncologyPathologyGenitourinary OncologyMolecular OncologyProstate DiseaseBenign Prostatic HyperplasiaBiomarkers In Genitourinary CancerBiomarkers In Urologic OncologyMolecular Tumor ProfilingProstate CancerProstatic PathologyMatrix Metalloproteinase Gene ExpressionPrognosis Of Prostate DiseaseProstate Cancer PrognosisProstate Tumor MarkersProstatic BiomarkersQuantitative Polymerase Chain ReactionReal-time Polymerase Chain Reaction (Pcr)Real-time Polymerase Chain Reaction Assays
BACKGROUND: Extracellular matrix homeostasis is strictly maintained by a coordinated balance between the expression of metalloproteinases (MMPs) and their inhibitors. The purpose of this study was to investigate whether the expression of MMP-9 and its specific inhibitors, TIMP-1 and RECK, are expressed in a reproducible, specific pattern and if the profiles are related to prognosis and clinical outcome in prostate cancer (PC). METHODS: MMP-9, TIMP-1, and RECK expression levels were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) in fresh-frozen malignant tissue specimens collected from 79 patients with clinically localized PC submitted to radical prostatectomy (RP). Frozen benign prostatic tissue from another 10 men with prostate cancer, also submitted to RP, was analyzed to determine if the profile of gene expression was maintained. The control group consisted of 11 patients with benign prostate hyperplasia (BPH). RESULTS: In the tumor samples, MMP-9 was overexpressed by 9.2 times, and TIMP-1 and RECK were underexpressed (0.75 and 0.80 times, respectively). Overexpression of MMP-9 was significantly related to PSA levels above 10 ng/mL (p=0.033). In addition, MMP-9 overexpression was related to biochemical recurrence, with a marginal statistical significance (p=0.089). MMP-9 was also overexpressed in benign tissues of patients with PC, as were TIMP-1 and RECK, in contrast to their underexpression in tumor samples. CONCLUSION: Our results show that MMP-9 is overexpressed and its negative regulators are underexpressed in PC tissue, emphasizing a possible role of MMP-9 in the carcinogenesis process. Additionally, we noticed a relationship between MMP-9 overexpression and increased levels of PSA, an important prognostic factor. In benign tissue adjacent to tumors, the MMP-9 equilibrium is likely maintained because the expression of its negative regulators is preserved.
25
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Amy R. Nelson, Barbara Fingleton, Mace L. Rothenberg et al. · Journal of Clinical Oncology · 2000 · 1.6K citations
Medicine, Cancer Biology, Oncology +14